BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11447087)

  • 21. Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits.
    Chen YL; Chang YJ; Jiang MJ
    Atherosclerosis; 1999 Mar; 143(1):115-23. PubMed ID: 10208486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody.
    Takeya M; Yoshimura T; Leonard EJ; Takahashi K
    Hum Pathol; 1993 May; 24(5):534-9. PubMed ID: 7684023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis.
    Fruebis J; Gonzalez V; Silvestre M; Palinski W
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1289-302. PubMed ID: 9261259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of atherosclerotic plaque on the enlargement of an experimental model of abdominal aortic aneurysm in rabbits.
    Kobayashi H; Matsushita M; Oda K; Nishikimi N; Sakurai T; Komori K
    Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):71-8. PubMed ID: 15177235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits.
    Worth NF; Berry CL; Thomas AC; Campbell JH
    Atherosclerosis; 2005 Nov; 183(1):65-73. PubMed ID: 15950232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2.
    Heil M; Ziegelhoeffer T; Wagner S; Fernández B; Helisch A; Martin S; Tribulova S; Kuziel WA; Bachmann G; Schaper W
    Circ Res; 2004 Mar; 94(5):671-7. PubMed ID: 14963007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photoangioplasty with local motexafin lutetium delivery reduces macrophages in a rabbit post-balloon injury model.
    Hayase M; Woodbum KW; Perlroth J; Miller RA; Baumgardner W; Yock PG; Yeung A
    Cardiovasc Res; 2001 Feb; 49(2):449-55. PubMed ID: 11164855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice.
    Dawson TC; Kuziel WA; Osahar TA; Maeda N
    Atherosclerosis; 1999 Mar; 143(1):205-11. PubMed ID: 10208497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
    Inoue S; Egashira K; Ni W; Kitamoto S; Usui M; Otani K; Ishibashi M; Hiasa K; Nishida K; Takeshita A
    Circulation; 2002 Nov; 106(21):2700-6. PubMed ID: 12438296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit.
    Bishop GG; McPherson JA; Sanders JM; Hesselbacher SE; Feldman MJ; McNamara CA; Gimple LW; Powers ER; Mousa SA; Sarembock IJ
    Circulation; 2001 Apr; 103(14):1906-11. PubMed ID: 11294811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma.
    Sica A; Saccani A; Bottazzi B; Bernasconi S; Allavena P; Gaetano B; Fei F; LaRosa G; Scotton C; Balkwill F; Mantovani A
    J Immunol; 2000 Jan; 164(2):733-8. PubMed ID: 10623817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.
    Bessler WK; Kim G; Hudson FZ; Mund JA; Mali R; Menon K; Kapur R; Clapp DW; Ingram DA; Stansfield BK
    Hum Mol Genet; 2016 Mar; 25(6):1129-39. PubMed ID: 26740548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the ApoE knockout mouse.
    Rayner K; Van Eersel S; Groot PH; Reape TJ
    J Vasc Res; 2000; 37(2):93-102. PubMed ID: 10754394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
    Tanaka T; Fukunaga Y; Itoh H; Doi K; Yamashita J; Chun TH; Inoue M; Masatsugu K; Saito T; Sawada N; Sakaguchi S; Arai H; Nakao K
    Eur J Pharmacol; 2005 Jan; 508(1-3):255-65. PubMed ID: 15680279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokines in the pathogenesis of vascular disease.
    Charo IF; Taubman MB
    Circ Res; 2004 Oct; 95(9):858-66. PubMed ID: 15514167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte chemoattractant protein-1 gene expression in injured pig artery coincides with early appearance of infiltrating monocyte/macrophages.
    Wysocki SJ; Zheng MH; Smith A; Lamawansa MD; Iacopetta BJ; Robertson TA; Papadimitriou JM; House AK; Norman PE
    J Cell Biochem; 1996 Sep; 62(3):303-13. PubMed ID: 8872602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of macrophage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP-1.
    Sakanashi Y; Takeya M; Yoshimura T; Feng L; Morioka T; Takahashi K
    J Leukoc Biol; 1994 Dec; 56(6):741-50. PubMed ID: 7527830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil treatment reduces atherosclerosis in the cholesterol-fed rabbit.
    Greenstein SM; Sun S; Calderon TM; Kim DY; Schreiber TC; Schechner RS; Tellis VA; Berman JW
    J Surg Res; 2000 Jun; 91(2):123-9. PubMed ID: 10839960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted.
    Horvath C; Welt FG; Nedelman M; Rao P; Rogers C
    Circ Res; 2002 Mar; 90(4):488-94. PubMed ID: 11884380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.